Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy

Ann Rheum Dis. 2005 May;64(5):788-9. doi: 10.1136/ard.2004.031187.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Female
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / physiology*
  • Humans
  • Infliximab
  • Spondylarthropathies / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Virus Activation / drug effects*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab